Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-03
2007-07-03
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
10790888
ABSTRACT:
Peptide factors isolated from skin following exposure to chemical or thermal injury and treatment with iodine preparations are capable of reducing or ameliorating the extent of injury when administered to other animals. Specific peptides, including fragments of histone H2A and fibrinopeptide A, and preferred derivatives of these peptides are disclosed. The extracts, peptides and pharmaceutical compositions according to the invention are useful for the preparation and treatment of inflammatory conditions and exposure to noxious stimuli.
REFERENCES:
patent: 6468537 (2002-10-01), Datta et al.
patent: 2003/0007964 (2003-01-01), Bae et al.
patent: 2004/0039157 (2004-02-01), Staton et al.
patent: WO 01/38522 (2001-05-01), None
Citron “Alzheimer's disease: treatments in discovery and development.” Nature Neurosci. 2002, 5, 1055.
Rizzello, et al. “The management of refractory Crohn's disease.” Ailment Pharmacol. Ther. 2002, 16, 40.
Korczyn & Nussbaum “Emerging therapies in the pharmacological treatment of Parkinson's Disease.” Drugs, 2002, 62(5), 775.
Skuk et al. “Experimental and therapeutic approaches to muscular dystrophies.” Curr. Op. Neur. 2002 15, 563.
Coussens & Werb “Inflammation and cancer.” Nature 2002, 420, 860.
Wiendl & Hohlfeld “Therapeutic approaches in multiple sclerosis.” Biodrugs 2002, 16(3) 183.
Ashcroft et al. “Therapeutic strategies for psoriasis.” J. Clin. Pharm. Ther. 2000, 25, 1.
Masuda & Sugiyama “Human fibrinopeptide A mediates allergic reaction in mice in the acute phase.” Peptides 2001, 22, 1511.
Scherer et al. “The effect of fibrinopeptides A and B on experimental allergic encephalomyelitis” Clin. exp. Immunol. 1980, 40, 49.
Steinman et al. “How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.” Ann. Neurol. 2006, 60(1), 12-21.
Myers et al. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997, 61(19), 1861-78.
Elgjo, K., et al., “Proliferation-dependent efect of skin extracts (chalone) on mouse epidermal cell flux at the G1-S, S-G2 and G2-M transitions”, Virchows Archiv. B. 1983, vol. 42, No. 2, pp. 143-151, abstract only.
Bradley Christina Marchetti
Tsang Cecilia J.
Winston & Strawn LLP
Yissum Research Development Company of the Hebrew University of
LandOfFree
Protective factors against inflammation, burns and noxious... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protective factors against inflammation, burns and noxious..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protective factors against inflammation, burns and noxious... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3781578